BC
BioCardia, Inc.
BCDA · NASDAQ
$1.10 -0.97% (-$0.01)
1M +18.01%
Market Cap $16.4M
P/E Ratio -
Div. Yield -
ROE 569.36%
Piotroski F-Score Weak
1/9Valuation
24 /100
Expensive P/B 6.06x
P/E N/A
P/FFO N/A
Growth
0 /100
Declining Book val. growth 43.23%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 246.91%
Asset turnover 0.00x
ROE 569.36%
Debt
100 /100
Low Debt/Equity 0.11x
Current ratio 2.09x
Int. coverage N/A
Stability
60 /100
Moderate Beta 0.49x
Profitable years 0
Rev. volatility 17.92%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na BCDA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Peter A. Altman
Employees
17
Headquarters
Sunnyvale
Nadcházející události
11 LIS
Earnings
Upcoming earnings report